Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

Kindred Biosciences, Inc. (KIN)

Cash Flow Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsJun-30-21Mar-31-21Jun-30-20Mar-31-20Dec-31-19Sep-30-19Jun-30-19Mar-31-19
   10-Q10-Q10-Q10-Q10-K10-Q10-Q10-Q
Net income  -9.1-9.724.0-22.8-15.7-15.3-14.3-16.1
Depreciation and amortization   [+]1.21.21.21.10.80.70.60.5
Asset impairment charges     3.5    
Stock-based compensation  1.52.51.92.11.81.81.91.9
Change in working capital   [+]3.6-3.6-3.0-0.9-0.62.0-1.3-4.9
Other operating activities  0.20.20.00.00.1-0.10.0-0.1
Cash from operations  -2.6-9.424.2-17.1-13.7-10.9-13.1-18.7
   
Capital expenditures   [+]-0.1-0.3-1.5-1.4-1.1-0.6-4.0-2.7
Purchases of short-term investments, net  22.7-2.2-10.017.0-9.0-0.7-20.0-9.7
Cash from investing  22.7-2.5-11.415.6-10.1-1.3-24.0-12.3
   
Issuance of common stock, net  13.213.7     43.1
Option exercises  0.80.00.10.10.70.20.50.7
Other cash from financing  1.4-0.50.3-0.41.319.61.10.8
Cash from financing  13.813.20.1-0.50.719.40.543.3
   
Free cash flow  -2.7-9.722.8-18.5-14.8-11.5-17.1-21.3
        Per share (diluted)  ($0.06)($0.24)$0.57($0.47)($0.38)($0.30)($0.44)($0.56)

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy